The median SaaS company in 2026 runs a 22% EBITDA margin. The median AI startup runs negative 15%. Both numbers can represent a good EBITDA for a tech company — depending on exactly three factors most founders never benchmark correctly.
Hayat Amin argues that raw EBITDA is the single most misunderstood number on a tech company's P&L. "Founders compare their EBITDA margin to industry averages and panic," Amin says. "But a 5% EBITDA margin in an AI company with $12M in defensible patent assets is a stronger business than a 30% margin SaaS company with zero IP protection." The benchmark that matters is not EBITDA alone — it is EBITDA relative to the intangible asset base underneath it.
This guide breaks down what a good EBITDA for a tech company actually looks like in 2026, sector by sector, stage by stage — and why the number on your income statement tells investors less than you think without the IP context that frames it.
What Is a Good EBITDA Margin for a SaaS Company?
A good EBITDA margin for a mature SaaS company in 2026 sits between 20% and 35%, with the median at approximately 22%. Early-stage SaaS companies (pre-$10M ARR) typically run negative to breakeven EBITDA as they invest in customer acquisition and product development. Growth-stage SaaS ($10M–$50M ARR) should target 10%–20%. At scale ($50M+ ARR), anything below 20% raises questions about unit economics.
These benchmarks come from public filings and the latest cloud index data. But raw EBITDA margins in SaaS hide a critical variable: R&D spend directed at building protectable intellectual property. A SaaS company spending 25% of revenue on R&D that produces patentable innovations is building future licensing optionality and exit premium — expenses that suppress current EBITDA but create compounding asset value.
The founders who benchmark only against headline EBITDA miss this. The investors pricing their deals do not.
What Is a Good EBITDA for an AI Company in 2026?
A good EBITDA for an AI company in 2026 depends on where the company sits in the stack, because the sector splits into three tiers with radically different margin profiles. Infrastructure-layer AI companies (compute, MLOps tooling) run 15%–25% EBITDA margins at scale. Application-layer AI companies (vertical SaaS with embedded AI) target 10%–20%. Foundation model companies and pre-revenue AI research labs run deeply negative — often negative 40% to negative 80% — while building the IP moats that justify their valuations.
This is where the EBITDA conversation breaks down for AI. A foundation model company with a negative 60% EBITDA margin and a 40-patent portfolio covering novel training architectures can command a 25x–30x revenue multiple. A profitable AI wrapper with 20% EBITDA but zero IP protection might trade at 4x–6x. The 2026 AI multiples data confirms this pattern: investors price defensibility, not current profitability.
Hayat Amin's IP-Adjusted EBITDA Model accounts for this gap. The framework adds back R&D spend directed at protectable innovations — patentable methods, proprietary datasets, documented trade secrets — and treats it as asset formation rather than expense. "When I show a founder their IP-adjusted EBITDA, the number is usually 15 to 25 points higher than their reported margin," Hayat Amin says. "That adjusted number is closer to what a sophisticated acquirer actually models."
How Do EBITDA Benchmarks Differ Across Hardware, Marketplace, and Deep Tech?
EBITDA benchmarks for a tech company vary dramatically by sub-sector, and using the wrong peer set is one of the fastest ways to misvalue your business. Hardware and IoT companies typically run 8%–18% EBITDA margins at maturity due to higher cost of goods sold. Marketplace platforms target 15%–25% at scale, with the best performers exceeding 30%. Deep-tech companies (quantum, biotech-adjacent, advanced materials) mirror AI research labs — deeply negative during the IP-building phase, then explosively profitable once licensing revenue activates.
The common thread across every sub-sector: companies that invest in building patent clusters during their negative-EBITDA phase capture disproportionate value at exit. Companies with patents are 10.2x more likely to secure early-stage funding — and that funding premium translates directly into longer runways to reach profitability without dilutive down rounds.
Why EBITDA Alone Misleads Investors and Founders
EBITDA as a standalone metric misleads because it treats all R&D as expense and all intangible assets as invisible. In a tech economy where intangible assets represent 90% of S&P 500 market capitalisation, this accounting convention creates a systematic blind spot that distorts how both investors and founders evaluate tech businesses.
Consider two companies with identical $20M revenue and 15% EBITDA margins. Company A spends $3M annually on R&D that produces no protectable IP — it builds features any competitor can replicate. Company B spends the same $3M on R&D that generates 8 granted patents, 3 provisional filings, and a documented trade secret programme covering its data pipeline. Their EBITDA is identical. Their enterprise value is not even close.
Beyond Elevation's client data shows the gap ranges from 1.5x to 3.5x on exit multiples between IP-protected and unprotected companies at the same EBITDA margin. Hayat Amin reminds founders that "EBITDA is the number your accountant optimises. IP-adjusted valuation is the number your acquirer pays."
How to Improve Your Tech Company's EBITDA Without Gutting R&D
The fastest path to EBITDA improvement that investors actually respect is not cutting R&D — it is monetising the IP your R&D has already created. Patent licensing revenue drops straight to EBITDA because the marginal cost of licensing an existing patent is near zero. A single licensing deal generating $500K in annual royalties on a $20M-revenue company improves EBITDA margin by 2.5 points with zero incremental cost.
Beyond Elevation has structured licensing programmes that moved portfolio companies from negative EBITDA to positive within 18 months — not by cutting spend, but by activating dormant patent assets. The DGS data monetisation engagement is a case study in this approach: a telecom company's proprietary dataset, previously treated as operational overhead, became a recurring revenue stream that transformed the P&L. For a deeper dive on the mechanics, see the patent licensing revenue model framework.
Three moves that improve EBITDA while building long-term value:
1. License non-core patents. Patents covering innovations you do not commercialise directly can generate royalties from companies in adjacent verticals. This is pure margin — revenue from assets that were previously sitting idle on your balance sheet.
2. Structure data monetisation. If your operations generate proprietary data, that data is a licensable asset. Data monetisation programmes typically generate 70%–90% gross margins because the data already exists.
3. Run Hayat Amin's IP Capture Audit. Most founders undercount their protectable assets by 60%–80%. A structured audit identifies innovations your engineers have already built that can be filed, protected, and monetised. The cost is minimal. The EBITDA impact compounds annually.
The EBITDA Benchmark Founders Should Actually Use
The right benchmark for a tech company is not raw EBITDA margin against a sector median. It is EBITDA margin plus IP asset formation rate against companies at the same stage with comparable defensibility. This is the metric Hayat Amin uses when advising founders ahead of fundraising conversations — and it consistently changes the narrative from "we need to cut burn" to "we need to capture and monetise what we have already built."
If your EBITDA looks weak on paper but your R&D is producing protectable, licensable IP, you do not have a profitability problem. You have a capture problem. Book a strategy session at beyondelevation.com to run the IP-Adjusted EBITDA Model on your own numbers — and see what your business is actually worth.
FAQ
What is a good EBITDA margin for a tech startup?
A good EBITDA margin for a tech startup depends on stage and sector. Pre-revenue and early-stage startups typically run negative EBITDA as they invest in product and customer acquisition. Growth-stage SaaS companies ($10M–$50M ARR) should target 10%–20%. AI startups at the infrastructure layer target 15%–25% at scale. The key is ensuring negative EBITDA reflects asset formation — protectable IP, defensible data, documented trade secrets — not just unrecoverable burn.
How does IP affect a tech company's EBITDA and valuation?
IP affects EBITDA in two ways. First, R&D spend that creates patentable innovations suppresses current EBITDA but builds intangible assets that drive higher exit multiples — typically 1.5x to 3.5x above unprotected peers. Second, licensing dormant patents generates high-margin revenue that drops straight to EBITDA. Companies that activate both levers outperform on both current margins and long-term valuation.
Is negative EBITDA always bad for a tech company?
No. Negative EBITDA during an IP-building phase can be rational if the spend produces defensible, protectable assets. AI foundation model companies and deep-tech startups regularly run negative 40%+ EBITDA margins while building patent portfolios that command 20x–30x revenue multiples. The question is not whether EBITDA is positive — it is whether the negative margin is building something a competitor cannot replicate.
What is the difference between EBITDA and adjusted EBITDA in tech?
Standard EBITDA adds back interest, taxes, depreciation, and amortisation. Adjusted EBITDA in tech typically adds back stock-based compensation, one-time restructuring costs, and non-recurring items. IP-adjusted EBITDA goes further — it reclassifies R&D spend directed at protectable innovations as asset formation, giving a more accurate picture of the company's economic profitability and underlying asset base.
How can I improve my tech company's EBITDA margin?
The highest-leverage EBITDA improvement for IP-rich tech companies is monetising existing intangible assets. Patent licensing, data licensing, and know-how licensing generate revenue at 70%–90% gross margins with near-zero incremental cost. One licensing programme on dormant patents can improve EBITDA margin by 2–5 percentage points. Beyond Elevation helps tech companies identify, protect, and monetise the IP assets their R&D has already created.